Survival in beta-thalassaemia major in the UK: data from the UK Thalassaemia Register
- PMID: 10885361
- DOI: 10.1016/S0140-6736(00)02357-6
Survival in beta-thalassaemia major in the UK: data from the UK Thalassaemia Register
Abstract
About 50% of UK patients with beta-thalassaemia major die before the age of 35 years, mainly because conventional iron-chelation therapy is too burdensome for full adherence. Patients require an individually-tailored treatment plan incorporating new, more tolerable approaches.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
